Coho Partners LTD Cut Abbott Laboratories (ABT) Holding By $13.37 Million; 0 Analysts Bullish Ferrellgas Partners, L.P. (FGP)

January 14, 2018 - By Vivian Park

Among 11 analysts covering Ferrellgas Partners L.P. (NYSE:FGP), 0 have Buy rating, 4 Sell and 7 Hold. Therefore 0 are positive. Ferrellgas Partners L.P. had 33 analyst reports since August 11, 2015 according to SRatingsIntel. The firm earned “Underperform” rating on Thursday, September 15 by RBC Capital Markets. The firm earned “Sell” rating on Tuesday, September 13 by Citigroup. The firm earned “Underweight” rating on Wednesday, September 28 by PiperJaffray. The firm has “Sell” rating given on Friday, June 10 by UBS. The stock of Ferrellgas Partners, L.P. (NYSE:FGP) has “Hold” rating given on Tuesday, January 9 by Citigroup. The stock has “Hold” rating by RBC Capital Markets on Monday, September 25. The stock has “Neutral” rating by Janney Capital on Tuesday, March 22. The stock has “Underweight” rating by Piper Jaffray on Wednesday, September 28. UBS maintained Ferrellgas Partners, L.P. (NYSE:FGP) on Thursday, September 29 with “Sell” rating. Barclays Capital maintained it with “Underweight” rating and $18 target in Wednesday, September 30 report. See Ferrellgas Partners, L.P. (NYSE:FGP) latest ratings:

09/01/2018 Broker: Citigroup Rating: Hold New Target: $4.5 Downgrade
07/12/2017 Broker: Raymond James Rating: Sell
29/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $6.0 Maintain
25/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $6.0 Maintain
20/08/2017 Broker: RBC Capital Markets Rating: Hold New Target: $6.0 Maintain

Coho Partners Ltd decreased Abbott Laboratories (ABT) stake by 6.76% reported in 2017Q3 SEC filing. Coho Partners Ltd sold 252,273 shares as Abbott Laboratories (ABT)’s stock declined 3.42%. The Coho Partners Ltd holds 3.48M shares with $185.74 million value, down from 3.73 million last quarter. Abbott Laboratories now has $102.42 billion valuation. The stock decreased 0.19% or $0.11 during the last trading session, reaching $58.84. About 6.32M shares traded or 6.93% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 14, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Investors sentiment decreased to 0.68 in 2017 Q3. Its down 0.11, from 0.79 in 2017Q2. It fall, as 17 investors sold Ferrellgas Partners, L.P. shares while 20 reduced holdings. 3 funds opened positions while 22 raised stakes. 6.00 million shares or 0.96% more from 5.94 million shares in 2017Q2 were reported. 62,852 are owned by Commonwealth Equity Svcs. Susquehanna Grp Limited Liability Partnership reported 91,584 shares. Manufacturers Life Ins The holds 3,825 shares. Wells Fargo & Mn invested in 0% or 13,295 shares. Creative Planning holds 0% of its portfolio in Ferrellgas Partners, L.P. (NYSE:FGP) for 67,355 shares. 112,000 are held by Novare Management Ltd. California Pub Employees Retirement Sys owns 214,000 shares for 0% of their portfolio. Bancorp Of Montreal Can holds 35,000 shares. Peak6 Invests Limited Partnership has invested 0% in Ferrellgas Partners, L.P. (NYSE:FGP). Cwm Ltd Llc holds 0% or 500 shares in its portfolio. Texas Yale has invested 0.08% in Ferrellgas Partners, L.P. (NYSE:FGP). Moreover, Huntington Steele Ltd has 0.04% invested in Ferrellgas Partners, L.P. (NYSE:FGP). Pnc Financial Service Inc reported 31,501 shares stake. The North Dakota-based Investment Centers Of America has invested 0.01% in Ferrellgas Partners, L.P. (NYSE:FGP). Moreover, Prescott Grp Inc Management Lc has 0.9% invested in Ferrellgas Partners, L.P. (NYSE:FGP) for 860,245 shares.

The stock decreased 1.93% or $0.08 during the last trading session, reaching $4.06. About 549,302 shares traded or 33.90% up from the average. Ferrellgas Partners, L.P. (NYSE:FGP) has declined 71.41% since January 14, 2017 and is downtrending. It has underperformed by 88.11% the S&P500.

Ferrellgas Partners, L.P. distributes and sells propane and related equipment and supplies primarily in the United States. The company has market cap of $398.46 million. It operates in two divisions: Propane Operations and Related Equipment Sales, and Midstream Operations. It currently has negative earnings. The firm transports propane to propane distribution locations, tanks on customersÂ’ premises, or to portable propane tanks delivered to retailers.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It turned negative, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Burney reported 48,047 shares. Salem Capital Mgmt reported 31,169 shares. Freestone Cap Holdings Ltd Com accumulated 44,849 shares. Perella Weinberg Prns Management Ltd Partnership reported 32,579 shares. 1.31M were reported by Retirement System Of Alabama. Schmidt P J Invest Mngmt accumulated 43,923 shares. Salient Tru Lta, a Texas-based fund reported 202,632 shares. Smith Chas P & Assocs Pa Cpas holds 0.17% of its portfolio in Abbott Laboratories (NYSE:ABT) for 21,733 shares. Cap Advisors Ltd Ltd has invested 0.02% of its portfolio in Abbott Laboratories (NYSE:ABT). Adirondack & accumulated 7,085 shares. Montgomery Investment Incorporated invested 0.53% in Abbott Laboratories (NYSE:ABT). Fiduciary holds 380,898 shares. Janney Montgomery Scott Ltd Limited Liability Company has 380,491 shares for 0.23% of their portfolio. Van Hulzen Asset Mngmt Limited holds 4,210 shares or 0.08% of its portfolio. 32,573 are owned by Cetera Advisor Netwr Ltd Liability.

Since August 1, 2017, it had 0 insider purchases, and 6 insider sales for $22.86 million activity. Bracken Sharon J also sold $98,323 worth of Abbott Laboratories (NYSE:ABT) on Tuesday, August 1. $2.74 million worth of Abbott Laboratories (NYSE:ABT) was sold by Contreras Jaime on Friday, September 22. Salvadori Daniel Gesua Sive also sold $3.31 million worth of Abbott Laboratories (NYSE:ABT) on Tuesday, September 26. On Wednesday, August 16 Fussell Stephen R sold $9.73 million worth of Abbott Laboratories (NYSE:ABT) or 196,550 shares.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24 before the open. They expect $0.73 earnings per share, up 12.31% or $0.08 from last year’s $0.65 per share. ABT’s profit will be $1.27 billion for 20.15 P/E if the $0.73 EPS becomes a reality. After $0.66 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Thursday, October 19 by Citigroup. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, July 23 report. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Thursday, August 31 with “Hold” rating. On Monday, April 17 the stock rating was maintained by Cowen & Co with “Buy”. As per Monday, August 10, the company rating was reinitiated by Credit Suisse. Northland Capital downgraded Abbott Laboratories (NYSE:ABT) rating on Thursday, September 28. Northland Capital has “Hold” rating and $60.0 target. On Friday, February 5 the stock rating was upgraded by Argus Research to “Buy”. The stock of Abbott Laboratories (NYSE:ABT) has “Hold” rating given on Thursday, July 20 by BMO Capital Markets. The rating was maintained by Cowen & Co on Tuesday, August 15 with “Buy”. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, October 9 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>